BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31366924)

  • 1. Designing development programs for non-traditional antibacterial agents.
    Rex JH; Fernandez Lynch H; Cohen IG; Darrow JJ; Outterson K
    Nat Commun; 2019 Jul; 10(1):3416. PubMed ID: 31366924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance: useful tool to design antibacterial agents for drug - resistant bacteria.
    Savjani JK; Gajjar AK; Savjani KT
    Mini Rev Med Chem; 2009 Feb; 9(2):194-205. PubMed ID: 19200024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial drug discovery in the 21st century.
    Bush K
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():10-7. PubMed ID: 15522035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Landscape and Future Perspective of Oxazolidinone Scaffolds Containing Antibacterial Drugs.
    Zhao Q; Xin L; Liu Y; Liang C; Li J; Jian Y; Li H; Shi Z; Liu H; Cao W
    J Med Chem; 2021 Aug; 64(15):10557-10580. PubMed ID: 34260235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GO-based antibacterial composites: Application and design strategies.
    Hu C; Yang Y; Lin Y; Wang L; Ma R; Zhang Y; Feng X; Wu J; Chen L; Shao L
    Adv Drug Deliv Rev; 2021 Nov; 178():113967. PubMed ID: 34509575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of novel oxazolidinone antibacterial agents active against multidrug-resistant bacteria.
    Barbachyn MR; Brickner SJ; Gadwood RC; Garmon SA; Grega KC; Hutchinson DK; Munesada K; Reischer RJ; Taniguchi M; Thomasco LM; Toops DS; Yamada H; Ford CW; Zurenko GE
    Adv Exp Med Biol; 1998; 456():219-38. PubMed ID: 10549371
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in the discovery of novel antibacterial agents during the year 2002.
    Harris CR; Thorarensen A
    Curr Med Chem; 2004 Aug; 11(16):2213-43. PubMed ID: 15279560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confronting the challenges of discovery of novel antibacterial agents.
    Singh SB
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3683-9. PubMed ID: 25017034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of structure-based design to antibacterial drug discovery.
    Cain R; Narramore S; McPhillie M; Simmons K; Fishwick CW
    Bioorg Chem; 2014 Aug; 55():69-76. PubMed ID: 24962384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents.
    Tari LW; Li X; Trzoss M; Bensen DC; Chen Z; Lam T; Zhang J; Lee SJ; Hough G; Phillipson D; Akers-Rodriguez S; Cunningham ML; Kwan BP; Nelson KJ; Castellano A; Locke JB; Brown-Driver V; Murphy TM; Ong VS; Pillar CM; Shinabarger DL; Nix J; Lightstone FC; Wong SE; Nguyen TB; Shaw KJ; Finn J
    PLoS One; 2013; 8(12):e84409. PubMed ID: 24386374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting virulence not viability in the search for future antibacterials.
    Heras B; Scanlon MJ; Martin JL
    Br J Clin Pharmacol; 2015 Feb; 79(2):208-15. PubMed ID: 24552512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial genome sequencing and drug discovery.
    Allsop AE
    Curr Opin Biotechnol; 1998 Dec; 9(6):637-42. PubMed ID: 9889137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric antibacterial materials: design, platforms and applications.
    Luo H; Yin XQ; Tan PF; Gu ZP; Liu ZM; Tan L
    J Mater Chem B; 2021 Mar; 9(12):2802-2815. PubMed ID: 33710247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Discovery of New Antibacterial Agents: Advances, Perspectives, Challenges.
    Jampilek J
    Curr Med Chem; 2018; 25(38):4972-5006. PubMed ID: 28925868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New targets and strategies for the development of antibacterial agents.
    Desnottes JF
    Trends Biotechnol; 1996 Apr; 14(4):134-40. PubMed ID: 8936435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New trends in antimicrobial development.
    Setti EL; Micetich RG
    Curr Med Chem; 1998 Apr; 5(2):101-13. PubMed ID: 9481036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where will new antibiotics come from?
    Walsh C
    Nat Rev Microbiol; 2003 Oct; 1(1):65-70. PubMed ID: 15040181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antibacterial-like activity on a silica surface: fluoroquinolones and their environmental metabolites.
    Lewis G; Juhasz A; Smith E
    Environ Sci Pollut Res Int; 2011 Aug; 19(7):2795-801. PubMed ID: 22311580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Microwave-Assisted Synthesis and in Vitro Antibacterial and Antifungal Activity of 2,5-Disubstituted Benzimidazole.
    Shi Y; Jiang K; Zheng R; Fu J; Yan L; Gu Q; Zhang Y; Lin F
    Chem Biodivers; 2019 Mar; 16(3):e1800510. PubMed ID: 30447139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.